Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease

Neha Gupta; Cesar A Virgen; Amrita Goyal; Andrew A Lane; Joseph H Antin; Sherrie J Divito; Cecilia Larocca

doi:10.1016/j.jdcr.2023.01.011

Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease

JAAD Case Rep. 2023 Jan 28:33:67-69. doi: 10.1016/j.jdcr.2023.01.011. eCollection 2023 Mar.

Authors

Neha Gupta^{1

2

3}, Cesar A Virgen^{1

2

4}, Amrita Goyal^{2

4}, Andrew A Lane^{4

5}, Joseph H Antin^{4

6}, Sherrie J Divito^{1

2

4}, Cecilia Larocca^{1

2

4}

Affiliations

¹ Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Case Western Reserve University School of Medicine, Cleveland, Ohio.
⁴ Harvard Medical School, Boston, Massachusetts.
⁵ Blastic Plasmacytoid Dendritic Cell Neoplasm Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁶ Department of Medical Oncology Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston, Massachusetts.

No abstract available

Keywords: GVHD, graft-versus-host disease; Grover's disease; HSCT, hematopoietic stem cell transplantation; NMSC, nonmelanoma skin cancers; RXR, retinoid X receptor; acitretin; cGVHD, chronic graft-versus-host disease; graft-versus-host disease.

Publication types

Case Reports